{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:43:26Z","timestamp":1789778606398,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejim.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T10:49:22Z","timestamp":1634294962000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Colchicine \u2013 new horizons for an ancient drug. Review based on the highest hierarchy of evidence"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-8858","authenticated-orcid":false,"given":"Ami","family":"Schattner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.10.002_bib0001","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2174\/1381612824666180115105850","article-title":"Isolating colchicine in 19th century: an old drug revisited","volume":"24","author":"Karamanou","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10.1016\/j.ejim.2021.10.002_bib0002","article-title":"Interventions for reducing inflammation in familial Mediterranean fever","volume":"10","author":"Wu","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2021.10.002_bib0003","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0004","unstructured":"ClinCalc drugstats database. The Top 300 of 2019. https:\/\/clincalc.com\/DrugStats\/Top300Drugs.aspx. Last accessed October 2021."},{"key":"10.1016\/j.ejim.2021.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(87)92641-9","article-title":"Colchicine for recurrent pericarditis","volume":"2","author":"de la Serna","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.10.002_bib0006","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0008","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicenter, double-blind, placebo-controlled, randomized trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejim.2021.10.002_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-019-1190-4","article-title":"Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome","volume":"19","author":"Lutschinger","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejim.2021.10.002_bib0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.recesp.2018.11.021","article-title":"Colchicine administered in the first episode of acute idiopathic pericarditis: a randomized multicenter open-label study","volume":"72","author":"Sambola","year":"2019","journal-title":"Rec Esp Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0011","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijcard.2012.09.052","article-title":"Post-cardiac injury syndromes. An emerging cause of pericardial diseases","volume":"168","author":"Imazio","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0012","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.amjcard.2011.06.025","article-title":"Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome","volume":"108","author":"Imazio","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0013","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00059-002-2376-5","article-title":"Colchicine for the prevention of the postpericardiotomy syndrome","volume":"27","author":"Finkelstein","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.ejim.2021.10.002_bib0014","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":"Colchicine for the prevention of the post-pericardiotomy syndrome (COPPS): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.10.002_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ahj.2011.05.017","article-title":"Colchicine prevents early postoperative pericardial and pleural effusions","volume":"162","author":"Imazio","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2021.10.002_bib0016","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/heartjnl-2015-307827","article-title":"Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomized controlled trial","volume":"101","author":"Meurin","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2021.10.002_bib0017","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation. The COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2021.10.002_bib0018","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2021.10.002_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2016.05.006","article-title":"Effect of colchicine on the incidence of atrial fibrillation in open heart surgery patients: END-AF Trial","volume":"178","author":"Tabbalat","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2021.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","article-title":"Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation. A randomized controlled study","volume":"60","author":"Deftereos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0021","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","article-title":"Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life","volume":"11","author":"Deftereos","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejim.2021.10.002_bib0022","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2017.08.039","article-title":"Colchicine for primary prevention of atrial fibrillation after open-heart surgery: systematic review and meta-analysis","volume":"249","author":"Lennerz","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0023","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ehjqcco\/qcx043","article-title":"Cost-effectiveness of colchicine treatment on post-operative atrial fibrillation events in patients of major cardiac surgery","volume":"4","author":"Barman","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.ejim.2021.10.002_bib0024","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"Back","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0026","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anti-cytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2021.10.002_bib0027","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2021.10.002_bib0028","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Martinez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2021.10.002_bib0029","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","article-title":"The role of interleukin-1 and the inflammasome in gout","volume":"56","author":"Pope","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.10.002_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine-update on the mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.10.002_bib0031","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2021.10.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Martinez","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2021.10.002_bib0033","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2021.10.002_bib0034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12265-020-09974-7","article-title":"Effects of colchicine on atherosclerotic plaque stabilization: a multimodality imaging study in an animal model","volume":"14","author":"Cecconi","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.ejim.2021.10.002_bib0035","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2021.10.002_bib0036","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2021.10.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial","volume":"13","author":"Shah","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2021.10.002_bib0038","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2021.10.002_bib0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2021.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Defteros","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0041","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0042","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0043","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/fca-2021-0027","article-title":"Lessons learned from large Cardiovascular Outcome Trials targeting inflammation in cardiovascular disease (CANTOS, CIRT, COLCOT and LoDoCo2)","volume":"17","author":"Samuel","year":"2021","journal-title":"Future Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0044","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-015-0068-3","article-title":"Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Verma","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejim.2021.10.002_bib0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/heartjnl-2015-308542","article-title":"Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis","volume":"102","author":"Hemkens","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2021.10.002_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.676771","article-title":"Efficacy and safety of colchicine in post-acute myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Diaz-Arocutipa","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0047","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.10.002_bib0048","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40261-021-01056-z","article-title":"Colchicine in patients with coronary artery disease with or without diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"41","author":"Kuzemczak","year":"2021","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ejim.2021.10.002_bib0049","doi-asserted-by":"crossref","DOI":"10.1007\/s40292-021-00460-y","article-title":"Effects of colchicine on cardiovascular outcomes in patients with coronary artery disease: a systematic review and one-stage and two-stage meta-analysis of randomized-controlled trials","author":"Teo","year":"2021","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.ejim.2021.10.002_bib0050","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Europ Heart J"},{"key":"10.1016\/j.ejim.2021.10.002_bib0051","article-title":"Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12,869 patients","author":"Andreis","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0052","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jnnp-2016-314817","article-title":"Anti-inflammatory approaches to ischaemic stroke prevention","volume":"89","author":"Kelly","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ejim.2021.10.002_bib0053","article-title":"Anti-inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack","volume":"5","author":"Coveney","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejim.2021.10.002_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104756","article-title":"Role of colchicine in stroke prevention: an updated meta-analysis","volume":"29","author":"Masson","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"10.1016\/j.ejim.2021.10.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242318","article-title":"Colchicine reduces lung injury in experimental acute respiratory distress syndrome","volume":"15","author":"Dupuis","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejim.2021.10.002_bib0056","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/rheumatology\/keaa217","article-title":"Why not use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease","volume":"59","author":"Piantoni","year":"2020","journal-title":"Rheumatol (Oxf)"},{"issue":"6","key":"10.1016\/j.ejim.2021.10.002_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2021.10.002_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001455","article-title":"Beneficial effects of colchicine for moderate to severe COVID-19: a randomized, double-blinded, placebo-controlled clinical trial","volume":"7","author":"Lopes","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.ejim.2021.10.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomized, double-blinded, adaptive, placebo-controlled, multicentre trial","author":"Tardif","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2021.10.002_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18087\/cardio.2021.2.n1560","article-title":"Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study","volume":"61","author":"Mareev","year":"2021","journal-title":"Kardiologia"},{"key":"10.1016\/j.ejim.2021.10.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13488","article-title":"Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","author":"Hariyanto","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107723","article-title":"Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: a systematic review, meta-analysis, and meta-regression","volume":"96","author":"Nawangsih","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0063","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.10.002_bib0064","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.semarthrit.2018.05.008","article-title":"Management of skin, mucosa and joint involvement of Beh\u00e7et's syndrome: a systematic review for update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"48","author":"Leccese","year":"2019","journal-title":"Sem Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.10.002_bib0066","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.1995.01690240061009","article-title":"Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial","volume":"131","author":"Sais","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejim.2021.10.002_bib0067","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/dom.13702","article-title":"Effects of colchicine in adults with the metabolic syndrome: a pilot randomized controlled trial","volume":"21","author":"Demidowich","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2021.10.002_bib0068","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41366-020-0598-3","article-title":"Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial","volume":"44","author":"Demidowich","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ejim.2021.10.002_bib0069","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00384-009-0794-z","article-title":"Colchicine is effective for short-term treatment of slow transit constipation: a double-blind placebo-controlled clinical trial","volume":"25","author":"Taghavi","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejim.2021.10.002_bib0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1590\/S0004-27492006000600006","article-title":"Colchicine in the treatment of the inflammatory phase of Graves' ophthalmopathy: a prospective and randomized trial with prednisone","volume":"69","author":"Stamato","year":"2006","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"10.1016\/j.ejim.2021.10.002_bib0071","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis","author":"Rambaldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ejim.2021.10.002_bib0072","article-title":"Non-steroid agents for idiopathic pulmonary fibrosis","author":"Spagnolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2021.10.002_bib0073","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/QAD.0000000000002845","article-title":"A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV","volume":"35","author":"Hays","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ejim.2021.10.002_bib0074","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med Res Rev"},{"issue":"suppl_1","key":"10.1016\/j.ejim.2021.10.002_bib0075","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on colchicine 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.ejim.2021.10.002_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.11.010","article-title":"The role of colchicine in atherosclerotic cardiovascular disease","author":"Kurup","year":"2021","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10.1016\/j.ejim.2021.10.002_bib0077","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Res Ther"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:36:58Z","timestamp":1760607418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521003320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":77,"alternative-id":["S0953620521003320"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.10.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine \u2013 new horizons for an ancient drug. Review based on the highest hierarchy of evidence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}